reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD012567-bib-0001,"Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, et al. ",FDG‐PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results, Tumori ,2016,102,    ,['citation-journal']," Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, et al. FDG‐PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.  Tumori 2016;102:103‐7. [DOI: 10.5301/tj.5000396]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.5301/tj.5000396', 'https://www.ncbi.nlm.nih.gov/pubmed/26350201', 'https://scholar.google.com/scholar_lookup?title=FDG‐PET/CT+to+predict+optimal+primary+cytoreductive+surgery+in+patients+with+advanced+ovarian+cancer:+preliminary+results+&author=A+Alessi&author=F+Martinelli&author=B+Padovano&author=G+Serafini&author=D+Lorusso&author=A+Lorenzoni&publication_year=2016&hl=en']",26350201,https://doi.org/10.5301/tj.5000396, Alessi 2016 {published data only}  ,included,CD012567-bbs2-0001,
CD012567-bib-0002,"Espada M, Garcia‐Flores JR, Jimenez M, Alvarez‐Moreno E, De Haro M, Gonzalez‐Cortijo L, et al. ",Diffusion‐weighted magnetic resonance imaging evaluation of intra‐abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma, European Radiology ,2013,23,    ,['citation-journal']," Espada M, Garcia‐Flores JR, Jimenez M, Alvarez‐Moreno E, De Haro M, Gonzalez‐Cortijo L, et al. Diffusion‐weighted magnetic resonance imaging evaluation of intra‐abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.  European Radiology 2013;23:2636‐42. [DOI: 10.1007/s00330‐013‐2837‐7]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s00330-013-2837-7', 'https://www.ncbi.nlm.nih.gov/pubmed/23604800', 'https://scholar.google.com/scholar_lookup?title=Diffusion‐weighted+magnetic+resonance+imaging+evaluation+of+intra‐abdominal+sites+of+implants+to+predict+likelihood+of+suboptimal+cytoreductive+surgery+in+patients+with+ovarian+carcinoma+&author=M+Espada&author=JR+Garcia‐Flores&author=M+Jimenez&author=E+Alvarez‐Moreno&author=M+Haro&author=L+Gonzalez‐Cortijo&publication_year=2013&hl=en']",23604800,https://doi.org/10.1007/s00330-013-2837-7, Espada 2013 {published data only}  ,included,CD012567-bbs2-0002,
CD012567-bib-0003,"Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL. ",Ovarian cancer: staging with CT and MR imaging, Radiology ,1995,197,    ,['citation-journal']," Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL. Ovarian cancer: staging with CT and MR imaging.  Radiology 1995;197:619‐26. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1148/radiology.197.3.7480729', 'https://www.ncbi.nlm.nih.gov/pubmed/7480729', 'https://scholar.google.com/scholar_lookup?title=Ovarian+cancer:+staging+with+CT+and+MR+imaging&author=R+Forstner&author=H+Hricak&author=KA+Occhipinti&author=CB+Powell&author=SD+Frankel&author=JL+Stern&publication_year=1995&hl=en']",7480729,https://doi.org/10.1148/radiology.197.3.7480729, Forstner 1995 {published data only}  ,included,CD012567-bbs2-0003,
CD012567-bib-0004,"Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, et al. ",Diagnostic value of whole body diffusion‐weighted MRI compared to computed tomography for pre‐operative assessment of patients suspected for ovarian cancer, European Journal of Cancer ,2017,83,    ,['citation-journal']," Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, et al. Diagnostic value of whole body diffusion‐weighted MRI compared to computed tomography for pre‐operative assessment of patients suspected for ovarian cancer.  European Journal of Cancer 2017;83:88‐98. [PUBMED: 28734146]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ejca.2017.06.010', 'https://www.ncbi.nlm.nih.gov/pubmed/28734146', 'https://scholar.google.com/scholar_lookup?title=Diagnostic+value+of+whole+body+diffusion‐weighted+MRI+compared+to+computed+tomography+for+pre‐operative+assessment+of+patients+suspected+for+ovarian+cancer+&author=K+Michielsen&author=R+Dresen&author=R+Vanslembrouck&author=F+Keyzer&author=F+Amant&author=E+Mussen&publication_year=2017&hl=en']",28734146,https://doi.org/10.1016/j.ejca.2017.06.010, Michielsen 2017 {published data only}  ,included,CD012567-bbs2-0004,
CD012567-bib-0005,"Shim SH, Lee SJ, Kim SO, Kim SN, Kim DY, Lee JJ, et al. ",Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients, Gynecologic Oncology ,2015,136,    ,['citation-journal']," Shim SH, Lee SJ, Kim SO, Kim SN, Kim DY, Lee JJ, et al. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.  Gynecologic Oncology 2015;136:30‐6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ygyno.2014.11.004', 'https://www.ncbi.nlm.nih.gov/pubmed/25448457', 'https://scholar.google.com/scholar_lookup?title=Nomogram+for+predicting+incomplete+cytoreduction+in+advanced+ovarian+cancer+patients&author=SH+Shim&author=SJ+Lee&author=SO+Kim&author=SN+Kim&author=DY+Kim&author=JJ+Lee&publication_year=2015&hl=en']",25448457,https://doi.org/10.1016/j.ygyno.2014.11.004, Shim 2015 {published data only}  ,included,CD012567-bbs2-0005,
CD012567-bib-0006,"Cotton F, Pellet O, Gilly FN, Granier A, Sournac L, Glehen O. ",MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis, European Journal of Surgical Oncology ,2006,32,    ,['citation-journal']," Cotton F, Pellet O, Gilly FN, Granier A, Sournac L, Glehen O. MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis.  European Journal of Surgical Oncology 2006;32(10):1212‐6. [PUBMED: 16762527]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ejso.2006.04.013', 'https://www.ncbi.nlm.nih.gov/pubmed/16762527', 'https://scholar.google.com/scholar_lookup?title=MRI+evaluation+of+bulky+tumor+masses+in+the+mesentery+and+bladder+involvement+in+peritoneal+carcinomatosis+&author=F+Cotton&author=O+Pellet&author=FN+Gilly&author=A+Granier&author=L+Sournac&author=O+Glehen&publication_year=2006&hl=en']",16762527,https://doi.org/10.1016/j.ejso.2006.04.013, Cotton 2006 {published data only}  ,excluded,CD012567-bbs2-0006," Other target condition. In patients with peritoneal carcinomatosis, MRI was used to evaluate tumour masses in the mesentery and bladder involvement.  "
CD012567-bib-0007,"Lopez‐Lopez V, Cascales‐Campos PA, Gil J, Frutos L, Andrade RJ, Fuster‐Quinonero M, et al. ","Use of (18)F‐FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue", European Journal of Radiology ,2016,85,    ,['citation-journal']," Lopez‐Lopez V, Cascales‐Campos PA, Gil J, Frutos L, Andrade RJ, Fuster‐Quinonero M, et al. Use of (18)F‐FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.  European Journal of Radiology 2016;85(10):1824‐8. [PUBMED: 27666623]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ejrad.2016.08.006', 'https://www.ncbi.nlm.nih.gov/pubmed/27666623', 'https://scholar.google.com/scholar_lookup?title=Use+of+(18)F‐FDG+PET/CT+in+the+preoperative+evaluation+of+patients+diagnosed+with+peritoneal+carcinomatosis+of+ovarian+origin,+candidates+to+cytoreduction+and+hipec.+A+pending+issue+&author=V+Lopez‐Lopez&author=PA+Cascales‐Campos&author=J+Gil&author=L+Frutos&author=RJ+Andrade&author=M+Fuster‐Quinonero&publication_year=2016&hl=en']",27666623,https://doi.org/10.1016/j.ejrad.2016.08.006, Lopez‐Lopez 2016 {published data only}  ,excluded,CD012567-bbs2-0007," Study population: only one patient received primary debulking surgery after preoperative evaluation by PET‐CT.  Also, Peritoneal Carcinomatosis Index was used as target condition instead of the completeness of debulking surgery.  "
CD012567-bib-0008,"Low RN, Barone RM. ",Combined diffusion‐weighted and gadolinium‐enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures, Annals of Surgical Oncology ,2012,19,    ,['citation-journal']," Low RN, Barone RM. Combined diffusion‐weighted and gadolinium‐enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures.  Annals of Surgical Oncology 2012;19(5):1394‐401. [PUBMED: 22302265]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1245/s10434-012-2236-3', 'https://www.ncbi.nlm.nih.gov/pubmed/22302265', 'https://scholar.google.com/scholar_lookup?title=Combined+diffusion‐weighted+and+gadolinium‐enhanced+MRI+can+accurately+predict+the+peritoneal+cancer+index+preoperatively+in+patients+being+considered+for+cytoreductive+surgical+procedures+&author=RN+Low&author=RM+Barone&publication_year=2012&hl=en']",22302265,https://doi.org/10.1245/s10434-012-2236-3, Low 2012 {published data only}  ,excluded,CD012567-bbs2-0008," Other target condition. MRI was used to predict Peritoneal Cancer Index in patients being considered for cytoreductive surgery, of whom 5 were diagnosed with ovarian cancer.  "
CD012567-bib-0009,"Pfannenberg C, Konigsrainer I, Aschoff P, Oksuz MO, Zieker D, Beckert S, et al. ",(18)F‐FDG‐PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, Annals of Surgical Oncology ,2009,16,    ,['citation-journal']," Pfannenberg C, Konigsrainer I, Aschoff P, Oksuz MO, Zieker D, Beckert S, et al. (18)F‐FDG‐PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.  Annals of Surgical Oncology 2009;16(5):1295‐303. [PUBMED: 19252950]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1245/s10434-009-0387-7', 'https://www.ncbi.nlm.nih.gov/pubmed/19252950', 'https://scholar.google.com/scholar_lookup?title=(18)F‐FDG‐PET/CT+to+select+patients+with+peritoneal+carcinomatosis+for+cytoreductive+surgery+and+hyperthermic+intraperitoneal+chemotherapy+&author=C+Pfannenberg&author=I+Konigsrainer&author=P+Aschoff&author=MO+Oksuz&author=D+Zieker&author=S+Beckert&publication_year=2009&hl=en']",19252950,https://doi.org/10.1245/s10434-009-0387-7, Pfannenberg 2009 {published data only}  ,excluded,CD012567-bbs2-0009," Other target condition. Peritoneal Cancer Index was estimated using PET‐CT to select patients for cytoreductive surgery or hyperthermic intraperitoneal chemotherapy, of whom 7 were diagnosed with ovarian cancer.  "
CD012567-bib-0010,"Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. ",Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer, Gynecologic Oncology ,2005,96,    ,['citation-journal']," Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.  Gynecologic Oncology 2005;96(2):301‐6. [PUBMED: 15661212]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ygyno.2004.06.054', 'https://www.ncbi.nlm.nih.gov/pubmed/15661212', 'https://scholar.google.com/scholar_lookup?title=Role+of+CT+and+MR+imaging+in+predicting+optimal+cytoreduction+of+newly+diagnosed+primary+epithelial+ovarian+cancer+&author=A+Qayyum&author=FV+Coakley&author=AC+Westphalen&author=H+Hricak&author=WT+Okuno&author=B+Powell&publication_year=2005&hl=en']",15661212,https://doi.org/10.1016/j.ygyno.2004.06.054, Qayyum 2005 {published data only}  ,excluded,CD012567-bbs2-0010, Required data could not be extracted from the published article and was not provided by study authors.  
CD012567-bib-0011,"Risum S, Hogdall C, Loft A, Berthelsen AK, Hogdall E, Nedergaard L, et al. ",Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography ‐ a prospective study, Gynecologic Oncology ,2008,108,    ,['citation-journal']," Risum S, Hogdall C, Loft A, Berthelsen AK, Hogdall E, Nedergaard L, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography ‐ a prospective study.  Gynecologic Oncology 2008;108:265‐70. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.ygyno.2007.11.002', 'https://www.ncbi.nlm.nih.gov/pubmed/18055006', 'https://scholar.google.com/scholar_lookup?title=Prediction+of+suboptimal+primary+cytoreduction+in+primary+ovarian+cancer+with+combined+positron+emission+tomography/computed+tomography+‐+a+prospective+study+&author=S+Risum&author=C+Hogdall&author=A+Loft&author=AK+Berthelsen&author=E+Hogdall&author=L+Nedergaard&publication_year=2008&hl=en']",18055006,https://doi.org/10.1016/j.ygyno.2007.11.002, Risum 2008 {published data only}  ,excluded,CD012567-bbs2-0011, Not a diagnostic test accuracy study 
CD012567-bib-0012,"Risum S, Loft A, Hogdall C, Berthelsen AK, Hogdall E, Lundvall L, et al. ",Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer, Acta Oncologica ,2011,50,    ,['citation-journal']," Risum S, Loft A, Hogdall C, Berthelsen AK, Hogdall E, Lundvall L, et al. Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.  Acta Oncologica 2011;50(3):415‐9. [PUBMED: 20698810]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3109/0284186X.2010.500296', 'https://www.ncbi.nlm.nih.gov/pubmed/20698810', 'https://scholar.google.com/scholar_lookup?title=Standardized+FDG+uptake+as+a+prognostic+variable+and+as+a+predictor+of+incomplete+cytoreduction+in+primary+advanced+ovarian+cancer+&author=S+Risum&author=A+Loft&author=C+Hogdall&author=AK+Berthelsen&author=E+Hogdall&author=L+Lundvall&publication_year=2011&hl=en']",20698810,https://doi.org/10.3109/0284186X.2010.500296, Risum 2011 {published data only}  ,excluded,CD012567-bbs2-0012, Not a diagnostic test accuracy study 
CD012567-bib-0013,"Baker TR, Piver MS, Hempling RE. ","Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma", Cancer ,1994,74,    ,['citation-journal']," Baker TR, Piver MS, Hempling RE. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma.  Cancer 1994;74(2):656‐63. [PUBMED: 8033045]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/1097-0142(19940715)74:2<656::AID-CNCR2820740218>3.0.CO;2-6', 'https://www.ncbi.nlm.nih.gov/pubmed/8033045', 'https://scholar.google.com/scholar_lookup?title=Long+term+survival+by+cytoreductive+surgery+to+less+than+1+cm,+induction+weekly+cisplatin+and+monthly+cisplatin,+doxorubicin,+and+cyclophosphamide+therapy+in+advanced+ovarian+adenocarcinoma+&author=TR+Baker&author=MS+Piver&author=RE+Hempling&publication_year=1994&hl=en']",8033045,https://doi.org/10.1002/1097-0142(19940715)74:2<656::AID-CNCR2820740218>3.0.CO;2-6, Baker 1994 ,additional,CD012567-bbs2-0013,
CD012567-bib-0014,"Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, et al. ",Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE, Cochrane Database of Systematic Reviews ,2013,,    ,['citation-journal']," Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, et al. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE.  Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.MR000022.pub3; PUBMED: 24022476]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.MR000022.pub3', 'https://www.ncbi.nlm.nih.gov/pubmed/24022476', 'https://scholar.google.com/scholar_lookup?title=Search+strategies+to+identify+diagnostic+accuracy+studies+in+MEDLINE+and+EMBASE&author=R+Beynon&author=MM+Leeflang&author=S+McDonald&author=A+Eisinga&author=RL+Mitchell&author=P+Whiting&publication_year=2013&hl=en']",24022476,https://doi.org/10.1002/14651858.MR000022.pub3, Beynon 2013 ,additional,CD012567-bbs2-0014,
CD012567-bib-0015,"Borley J, Wilhelm‐Benartzi C, Yazbek J, Williamson R, Bharwani N, Stewart V, et al. ",Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer, British Journal of Obstetrics and Gynaecology ,2015,122,    ,['citation-journal']," Borley J, Wilhelm‐Benartzi C, Yazbek J, Williamson R, Bharwani N, Stewart V, et al. Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.  British Journal of Obstetrics and Gynaecology 2015;122(6):843‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/1471-0528.12992', 'https://www.ncbi.nlm.nih.gov/pubmed/25132394', 'https://scholar.google.com/scholar_lookup?title=Radiological+predictors+of+cytoreductive+outcomes+in+patients+with+advanced+ovarian+cancer+&author=J+Borley&author=C+Wilhelm‐Benartzi&author=J+Yazbek&author=R+Williamson&author=N+Bharwani&author=V+Stewart&publication_year=2015&hl=en']",25132394,https://doi.org/10.1111/1471-0528.12992, Borley 2015 ,additional,CD012567-bbs2-0015,
CD012567-bib-0016,"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. ",Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta‐analysis, Journal of Clinical Oncology ,2002,20,    ,['citation-journal']," Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta‐analysis.  Journal of Clinical Oncology 2002;20(5):1248‐59.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2002.20.5.1248', 'https://www.ncbi.nlm.nih.gov/pubmed/11870167', 'https://scholar.google.com/scholar_lookup?title=Survival+effect+of+maximal+cytoreductive+surgery+for+advanced+ovarian+carcinoma+during+the+platinum+era:+a+meta‐analysis+&author=RE+Bristow&author=RS+Tomacruz&author=DK+Armstrong&author=EL+Trimble&author=FJ+Montz&publication_year=2002&hl=en']",11870167,https://doi.org/10.1200/JCO.2002.20.5.1248, Bristow 2002 ,additional,CD012567-bbs2-0016,
CD012567-bib-0017,"Deeks JJ, Bossuyt PM, Gatsonis C, (editors). ","Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013",,2013,,    ,['citation-other']," Deeks JJ, Bossuyt PM, Gatsonis C, (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org/2013.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Cochrane+Handbook+for+Systematic+Reviews+of+Diagnostic+Test+Accuracy+Version+1.0.0.+The+Cochrane+Collaboration,+2013+&author=JJ+Deeks&author=PM+Bossuyt&author=C+Gatsonis&author=+(editors)&publication_year=2013&hl=en']",,, Deeks 2013 ,additional,CD012567-bbs2-0017,
CD012567-bib-0018,"Du Bois A, Reuss A, Pujade‐Lauraine E, Harter P, Ray‐Coquard I, Pfisterer J, Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO‐OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). ",Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials, Cancer ,2009,115,    ,['citation-journal']," Du Bois A, Reuss A, Pujade‐Lauraine E, Harter P, Ray‐Coquard I, Pfisterer J, Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO‐OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials.  Cancer 2009;115(6):1234‐44. [PUBMED: 19189349]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/cncr.24149', 'https://www.ncbi.nlm.nih.gov/pubmed/19189349', 'https://scholar.google.com/scholar_lookup?title=Role+of+surgical+outcome+as+prognostic+factor+in+advanced+epithelial+ovarian+cancer:+a+combined+exploratory+analysis+of+3+prospectively+randomized+phase+3+multicenter+trials+&author=A+DuBois&author=A+Reuss&author=E+Pujade‐Lauraine&author=P+Harter&author=I+Ray‐Coquard&author=J+Pfisterer&publication_year=2009&hl=en']",19189349,https://doi.org/10.1002/cncr.24149, Du Bois 2009 ,additional,CD012567-bbs2-0018,
CD012567-bib-0019,"Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, et al. ",Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients, Journal of the National Cancer Institute ,2006,98,    ,['citation-journal']," Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.  Journal of the National Cancer Institute 2006;98(3):172‐80.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/jnci/djj019', 'https://www.ncbi.nlm.nih.gov/pubmed/16449677', 'https://scholar.google.com/scholar_lookup?title=Effect+of+surgeon+specialty+on+processes+of+care+and+outcomes+for+ovarian+cancer+patients&author=CC+Earle&author=D+Schrag&author=BA+Neville&author=KR+Yabroff&author=M+Topor&author=A+Fahey&publication_year=2006&hl=en']",16449677,https://doi.org/10.1093/jnci/djj019, Earle 2006 ,additional,CD012567-bbs2-0019,
CD012567-bib-0020,"Elattar A, Bryant A, Winter‐Roach BA, Hatem M, Naik R. ",Optimal primary surgical treatment for advanced epithelial ovarian cancer, Cochrane Database of Systematic Reviews ,2011,,    ,['citation-journal']," Elattar A, Bryant A, Winter‐Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer.  Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD007565.pub2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD007565.pub2', 'https://www.ncbi.nlm.nih.gov/pubmed/21833960', 'https://scholar.google.com/scholar_lookup?title=Optimal+primary+surgical+treatment+for+advanced+epithelial+ovarian+cancer&author=A+Elattar&author=A+Bryant&author=BA+Winter‐Roach&author=M+Hatem&author=R+Naik&publication_year=2011&hl=en']",21833960,https://doi.org/10.1002/14651858.CD007565.pub2, Elattar 2011 ,additional,CD012567-bbs2-0020,
CD012567-bib-0021,"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. ","GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11",,,,. globocan.iarc.fr (accessed 27 May 2015).   ,['citation-other']," Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. globocan.iarc.fr (accessed 27 May 2015).    ",[],,, Ferlay 2012 ,additional,CD012567-bbs2-0021,
CD012567-bib-0022,"Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D, et al. AGO Study Group. ",Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II, International Journal of Gynecological Cancer ,2011,21,    ,['citation-journal']," Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D, et al. AGO Study Group. Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II.  International Journal of Gynecological Cancer 2011;21(2):289‐95. [PUBMED: 21270612]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/IGC.0b013e31820aaafd', 'https://www.ncbi.nlm.nih.gov/pubmed/21270612', 'https://scholar.google.com/scholar_lookup?title=Prospective+validation+study+of+a+predictive+score+for+operability+of+recurrent+ovarian+cancer:+the+Multicenter+Intergroup+Study+DESKTOP+II+&author=P+Harter&author=J+Sehouli&author=A+Reuss&author=A+Hasenburg&author=G+Scambia&author=D+Cibula&publication_year=2011&hl=en']",21270612,https://doi.org/10.1097/IGC.0b013e31820aaafd, Harter 2011 ,additional,CD012567-bbs2-0022,
CD012567-bib-0023,"Hsu J, Brozek JL, Terracciano L, Kreis J, Compalati E, Stein AT, et al. ",Application of GRADE: making evidence‐based recommendations about diagnostic tests in clinical practice guidelines, Implementation Science ,2011,6,    ,['citation-journal']," Hsu J, Brozek JL, Terracciano L, Kreis J, Compalati E, Stein AT, et al. Application of GRADE: making evidence‐based recommendations about diagnostic tests in clinical practice guidelines.  Implementation Science 2011;6:62. [PUBMED: 21663655]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/1748-5908-6-62', 'https://www.ncbi.nlm.nih.gov/pubmed/21663655', 'https://scholar.google.com/scholar_lookup?title=Application+of+GRADE:+making+evidence‐based+recommendations+about+diagnostic+tests+in+clinical+practice+guidelines+&author=J+Hsu&author=JL+Brozek&author=L+Terracciano&author=J+Kreis&author=E+Compalati&author=AT+Stein&publication_year=2011&hl=en']",21663655,https://doi.org/10.1186/1748-5908-6-62, Hsu 2011 ,additional,CD012567-bbs2-0023,
CD012567-bib-0024,"Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomaki J, Oksa S, et al. ",A prospective comparison of integrated FDG‐PET/contrast‐enhanced CT and contrast‐enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer, Gynecologic Oncology ,2013,131,    ,['citation-journal']," Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomaki J, Oksa S, et al. A prospective comparison of integrated FDG‐PET/contrast‐enhanced CT and contrast‐enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.  Gynecologic Oncology 2013;131(2):389‐94. [PUBMED: 23994535]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ygyno.2013.08.023', 'https://www.ncbi.nlm.nih.gov/pubmed/23994535', 'https://scholar.google.com/scholar_lookup?title=A+prospective+comparison+of+integrated+FDG‐PET/contrast‐enhanced+CT+and+contrast‐enhanced+CT+for+pretreatment+imaging+of+advanced+epithelial+ovarian+cancer+&author=J+Hynninen&author=J+Kemppainen&author=M+Lavonius&author=J+Virtanen&author=J+Matomaki&author=S+Oksa&publication_year=2013&hl=en']",23994535,https://doi.org/10.1016/j.ygyno.2013.08.023, Hynninen 2013 ,additional,CD012567-bbs2-0024,
CD012567-bib-0025,"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, et al. ","Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open‐label, randomised, controlled, non‐inferiority trial", Lancet ,2015,386,    ,['citation-journal']," Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open‐label, randomised, controlled, non‐inferiority trial.  Lancet 2015;386(9990):249‐57.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(14)62223-6', 'https://www.ncbi.nlm.nih.gov/pubmed/26002111', 'https://scholar.google.com/scholar_lookup?title=Primary+chemotherapy+versus+primary+surgery+for+newly+diagnosed+advanced+ovarian+cancer+(CHORUS):+an+open‐label,+randomised,+controlled,+non‐inferiority+trial+&author=S+Kehoe&author=J+Hook&author=M+Nankivell&author=GC+Jayson&author=H+Kitchener&author=T+Lopes&publication_year=2015&hl=en']",26002111,https://doi.org/10.1016/S0140-6736(14)62223-6, Kehoe 2015 ,additional,CD012567-bbs2-0025,
CD012567-bib-0026,"Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. ","Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013",,,,. Available from srdta.cochrane.org.   ,['citation-other']," Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2013. Available from srdta.cochrane.org.    ",[],,, Macaskill 2010 ,additional,CD012567-bbs2-0026,
CD012567-bib-0027,"Mercado C, Zingmond D, Karlan BY, Sekaris E, Gross J, Maggard‐Gibbons M, et al. ",Quality of care in advanced ovarian cancer: the importance of provider specialty, Gynecologic Oncology ,2010,117,    ,['citation-journal']," Mercado C, Zingmond D, Karlan BY, Sekaris E, Gross J, Maggard‐Gibbons M, et al. Quality of care in advanced ovarian cancer: the importance of provider specialty.  Gynecologic Oncology 2010;117(1):18‐22.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ygyno.2009.12.033', 'https://www.ncbi.nlm.nih.gov/pubmed/20106512', 'https://scholar.google.com/scholar_lookup?title=Quality+of+care+in+advanced+ovarian+cancer:+the+importance+of+provider+specialty&author=C+Mercado&author=D+Zingmond&author=BY+Karlan&author=E+Sekaris&author=J+Gross&author=M+Maggard‐Gibbons&publication_year=2010&hl=en']",20106512,https://doi.org/10.1016/j.ygyno.2009.12.033, Mercado 2010 ,additional,CD012567-bbs2-0027,
CD012567-bib-0028,"Morrison J, Haldar K, Kehoe S, Lawrie TA. ",Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer, Cochrane Database of Systematic Reviews ,2012,,    ,['citation-journal']," Morrison J, Haldar K, Kehoe S, Lawrie TA. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.  Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD005343.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD005343.pub3', 'https://scholar.google.com/scholar_lookup?title=Chemotherapy+versus+surgery+for+initial+treatment+in+advanced+ovarian+epithelial+cancer&author=J+Morrison&author=K+Haldar&author=S+Kehoe&author=TA+Lawrie&publication_year=2012&hl=en']",,https://doi.org/10.1002/14651858.CD005343.pub3, Morrison 2012 ,additional,CD012567-bbs2-0028,
CD012567-bib-0029,"Mutch DG, Prat J. ","2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer", Gynecologic Oncology ,2014,133,    ,['citation-journal']," Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.  Gynecologic Oncology 2014;133(3):401‐4.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ygyno.2014.04.013', 'https://www.ncbi.nlm.nih.gov/pubmed/24878391', 'https://scholar.google.com/scholar_lookup?title=2014+FIGO+staging+for+ovarian,+fallopian+tube+and+peritoneal+cancer&author=DG+Mutch&author=J+Prat&publication_year=2014&hl=en']",24878391,https://doi.org/10.1016/j.ygyno.2014.04.013, Mutch 2014 ,additional,CD012567-bbs2-0029,
CD012567-bib-0030,National Cancer Institute. ,"PDQ® ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment",,,,. www.cancer.gov/types/ovarian/hp/ovarian‐epithelial‐treatment‐pdq (accessed 8 June 2015).   ,['citation-other']," National Cancer Institute. PDQ® ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment. www.cancer.gov/types/ovarian/hp/ovarian‐epithelial‐treatment‐pdq (accessed 8 June 2015).    ",[],,, NCI 2015 ,additional,CD012567-bbs2-0030,
CD012567-bib-0031,National Institute for Health and Clinical Excellence (NICE). ,Ovarian cancer: the recognition and initial management of ovarian cancer,,,,. www.nice.org.uk/guidance/CG122/ (accessed prior to 16 September 2018).   ,['citation-other'], National Institute for Health and Clinical Excellence (NICE). Ovarian cancer: the recognition and initial management of ovarian cancer. www.nice.org.uk/guidance/CG122/ (accessed prior to 16 September 2018).    ,[],,, NICE 2011 ,additional,CD012567-bbs2-0031,
CD012567-bib-0032,"Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. ",Symptoms of ovarian cancer, Obstetrics and Gynecology ,2001,98,    ,['citation-journal']," Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer.  Obstetrics and Gynecology 2001;98(2):212‐7.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/11506835', 'https://scholar.google.com/scholar_lookup?title=Symptoms+of+ovarian+cancer&author=SH+Olson&author=L+Mignone&author=C+Nakraseive&author=TA+Caputo&author=RR+Barakat&author=S+Harlap&publication_year=2001&hl=en']",11506835,, Olson 2001 ,additional,CD012567-bbs2-0032,
CD012567-bib-0033,"Prat J, FIGO Committee on Gynecologic Oncology. ","Staging classification for cancer of the ovary, fallopian tube, and peritoneum", International Journal of Gynaecology and Obstetrics ,2014,124,    ,['citation-journal']," Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum.  International Journal of Gynaecology and Obstetrics 2014;124(1):1‐5.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ijgo.2013.10.001', 'https://www.ncbi.nlm.nih.gov/pubmed/24219974', 'https://scholar.google.com/scholar_lookup?title=Staging+classification+for+cancer+of+the+ovary,+fallopian+tube,+and+peritoneum&author=J+Prat&publication_year=2014&hl=en']",24219974,https://doi.org/10.1016/j.ijgo.2013.10.001, Prat 2014 ,additional,CD012567-bbs2-0033,
CD012567-bib-0034,"Nordic Cochrane Centre, The Cochrane Collaboration. ",Review Manager 5 (RevMan 5),,2014,,.   ,['citation-other']," Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, Review Manager 2014 [Computer program] ,additional,CD012567-bbs2-0034,
CD012567-bib-0035,"Roett MA, Evans P. ",Ovarian cancer: an overview, American Family Physician ,2009 Sep,80,    ,['citation-journal']," Roett MA, Evans P. Ovarian cancer: an overview.  American Family Physician 2009 Sep;80(6):609‐16.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/19817326', 'https://scholar.google.com/scholar_lookup?title=Ovarian+cancer:+an+overview&author=MA+Roett&author=P+Evans&publication_year=2009Sep&hl=en']",19817326,, Roett 2009 ,additional,CD012567-bbs2-0035,
CD012567-bib-0036,"Rutten MJ, Leeflang MM, Kenter GG, Mol BW, Buist M. ",Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Rutten MJ, Leeflang MM, Kenter GG, Mol BW, Buist M. Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer.  Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD009786.pub2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009786.pub2', 'https://www.ncbi.nlm.nih.gov/pubmed/24563459', 'https://scholar.google.com/scholar_lookup?title=Laparoscopy+for+diagnosing+resectability+of+disease+in+patients+with+advanced+ovarian+cancer+&author=MJ+Rutten&author=MM+Leeflang&author=GG+Kenter&author=BW+Mol&author=M+Buist&publication_year=2014&hl=en']",24563459,https://doi.org/10.1002/14651858.CD009786.pub2, Rutten 2014 ,additional,CD012567-bbs2-0036,
CD012567-bib-0037,"Rutten MJ, Van de Vrie R, Bruining A, Spijkerboer AM, Mol BW, Kenter GG, et al. ",Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models, International Journal of Gynecological Cancer ,2015,25,    ,['citation-journal']," Rutten MJ, Van de Vrie R, Bruining A, Spijkerboer AM, Mol BW, Kenter GG, et al. Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models.  International Journal of Gynecological Cancer 2015;25(3):407‐15. [PUBMED: 25695545]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/IGC.0000000000000368', 'https://www.ncbi.nlm.nih.gov/pubmed/25695545', 'https://scholar.google.com/scholar_lookup?title=Predicting+surgical+outcome+in+patients+with+International+Federation+of+Gynecology+and+Obstetrics+stage+III+or+IV+ovarian+cancer+using+computed+tomography:+a+systematic+review+of+prediction+models+&author=MJ+Rutten&author=R+Vrie&author=A+Bruining&author=AM+Spijkerboer&author=BW+Mol&author=GG+Kenter&publication_year=2015&hl=en']",25695545,https://doi.org/10.1097/IGC.0000000000000368, Rutten 2015 ,additional,CD012567-bbs2-0037,
CD012567-bib-0038,"Rutten MJ, Van Meurs HS, Van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, Van Gorp T, et al. ",Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial, Journal of Clinical Oncology ,2017,35,    ,['citation-journal']," Rutten MJ, Van Meurs HS, Van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, Van Gorp T, et al. Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial.  Journal of Clinical Oncology 2017;35(6):613‐21. [PUBMED: 28029317]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2016.69.2962', 'https://www.ncbi.nlm.nih.gov/pubmed/28029317', 'https://scholar.google.com/scholar_lookup?title=Laparoscopy+to+predict+the+result+of+primary+cytoreductive+surgery+in+patients+with+advanced+ovarian+cancer:+a+randomized+controlled+trial+&author=MJ+Rutten&author=HS+Meurs&author=R+Vrie&author=KN+Gaarenstroom&author=CA+Naaktgeboren&author=T+Gorp&publication_year=2017&hl=en']",28029317,https://doi.org/10.1200/JCO.2016.69.2962, Rutten 2017 ,additional,CD012567-bbs2-0038,
CD012567-bib-0039,"Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, et al. ",Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection, Journal of the National Cancer Institute ,2006,98,    ,['citation-journal']," Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.  Journal of the National Cancer Institute 2006;98(3):163‐71.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/jnci/djj018', 'https://www.ncbi.nlm.nih.gov/pubmed/16449676', 'https://scholar.google.com/scholar_lookup?title=Associations+between+hospital+and+surgeon+procedure+volumes+and+patient+outcomes+after+ovarian+cancer+resection+&author=D+Schrag&author=C+Earle&author=F+Xu&author=KS+Panageas&author=KR+Yabroff&author=RE+Bristow&publication_year=2006&hl=en']",16449676,https://doi.org/10.1093/jnci/djj018, Schrag 2006 ,additional,CD012567-bbs2-0039,
CD012567-bib-0040,"Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. ",GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies, BMJ ,2008,336,    ,['citation-journal']," Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies.  BMJ 2008;336:1106‐10.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.39500.677199.AE', 'https://www.ncbi.nlm.nih.gov/pubmed/18483053', 'https://scholar.google.com/scholar_lookup?title=GRADE:+grading+quality+of+evidence+and+strength+of+recommendations+for+diagnostic+tests+and+strategies+&author=HJ+Schünemann&author=AD+Oxman&author=J+Brozek&author=P+Glasziou&author=R+Jaeschke&author=GE+Vist&publication_year=2008&hl=en']",18483053,https://doi.org/10.1136/bmj.39500.677199.AE, Schünemann 2008 ,additional,CD012567-bbs2-0040,
CD012567-bib-0041,"Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, et al. ","A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA‐125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer", Gynecologic Oncology ,2014,134,    ,['citation-journal']," Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA‐125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.  Gynecologic Oncology 2014;134(3):455‐61.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ygyno.2014.07.002', 'https://www.ncbi.nlm.nih.gov/pubmed/25019568', 'https://scholar.google.com/scholar_lookup?title=A+multicenter+prospective+trial+evaluating+the+ability+of+preoperative+computed+tomography+scan+and+serum+CA‐125+to+predict+suboptimal+cytoreduction+at+primary+debulking+surgery+for+advanced+ovarian,+fallopian+tube,+and+peritoneal+cancer+&author=RS+Suidan&author=PT+Ramirez&author=DM+Sarasohn&author=JB+Teitcher&author=S+Mironov&author=RB+Iyer&publication_year=2014&hl=en']",25019568,https://doi.org/10.1016/j.ygyno.2014.07.002, Suidan 2014 ,additional,CD012567-bbs2-0041,
CD012567-bib-0042,"Van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. ",Investigation of publication bias in meta‐analyses of diagnostic test accuracy: a meta‐epidemiological study, BMC Medical Research Methodology ,2014,14,    ,['citation-journal']," Van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM. Investigation of publication bias in meta‐analyses of diagnostic test accuracy: a meta‐epidemiological study.  BMC Medical Research Methodology 2014;14:70. [DOI: 10.1186/1471‐2288‐14‐70; PUBMED: 24884381]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/1471-2288-14-70', 'https://www.ncbi.nlm.nih.gov/pubmed/24884381', 'https://scholar.google.com/scholar_lookup?title=Investigation+of+publication+bias+in+meta‐analyses+of+diagnostic+test+accuracy:+a+meta‐epidemiological+study+&author=WA+Enst&author=E+Ochodo&author=RJ+Scholten&author=L+Hooft&author=MM+Leeflang&publication_year=2014&hl=en']",24884381,https://doi.org/10.1186/1471-2288-14-70, Van Enst 2014 ,additional,CD012567-bbs2-0042,
CD012567-bib-0043,"Vergote I, Van Gorp T, Amant F, Leunen K, Neven P, Berteloot P. ",Timing of debulking surgery in advanced ovarian cancer, International Journal of Gynecological Cancer ,2008,18,    ,['citation-journal']," Vergote I, Van Gorp T, Amant F, Leunen K, Neven P, Berteloot P. Timing of debulking surgery in advanced ovarian cancer.  International Journal of Gynecological Cancer 2008;18(suppl 1):11‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1525-1438.2007.01098.x', 'https://www.ncbi.nlm.nih.gov/pubmed/18336393', 'https://scholar.google.com/scholar_lookup?title=Timing+of+debulking+surgery+in+advanced+ovarian+cancer&author=I+Vergote&author=T+Gorp&author=F+Amant&author=K+Leunen&author=P+Neven&author=P+Berteloot&publication_year=2008&hl=en']",18336393,https://doi.org/10.1111/j.1525-1438.2007.01098.x, Vergote 2008 ,additional,CD012567-bbs2-0043,
CD012567-bib-0044,"Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. ",Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, New England Journal of Medicine ,2010,363,    ,['citation-journal']," Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.  New England Journal of Medicine 2010;363(10):943‐53.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJMoa0908806', 'https://www.ncbi.nlm.nih.gov/pubmed/20818904', 'https://scholar.google.com/scholar_lookup?title=Neoadjuvant+chemotherapy+or+primary+surgery+in+stage+IIIC+or+IV+ovarian+cancer&author=I+Vergote&author=CG+Tropé&author=F+Amant&author=GB+Kristensen&author=T+Ehlen&author=N+Johnson&publication_year=2010&hl=en']",20818904,https://doi.org/10.1056/NEJMoa0908806, Vergote 2010 ,additional,CD012567-bbs2-0044,
CD012567-bib-0045,"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2 Group. ",QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies, Annals of Internal Medicine ,2011,18,    ,['citation-journal']," Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2 Group. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies.  Annals of Internal Medicine 2011;18(155):529‐36.    Link to article     Google Scholar     ","['https://doi.org/10.7326/0003-4819-155-8-201110180-00009', 'https://scholar.google.com/scholar_lookup?title=QUADAS‐2:+a+revised+tool+for+the+quality+assessment+of+diagnostic+accuracy+studies&author=PF+Whiting&author=AW+Rutjes&author=ME+Westwood&author=S+Mallett&author=JJ+Deeks&author=JB+Reitsma&publication_year=2011&hl=en']",,https://doi.org/10.7326/0003-4819-155-8-201110180-00009, Whiting 2011 ,additional,CD012567-bbs2-0045,
